103 related articles for article (PubMed ID: 7535816)
1. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.
Poindexter NJ; Naziruddin B; McCourt DW; Mohanakumar T
J Immunol; 1995 Apr; 154(8):3880-7. PubMed ID: 7535816
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as a source of high avidity peptide-specific human CTL.
Münz C; Obst R; Osen W; Stevanović S; Rammensee HG
J Immunol; 1999 Jan; 162(1):25-34. PubMed ID: 9886366
[TBL] [Abstract][Full Text] [Related]
3. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
4. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
5. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
Skipper JC; Kittlesen DJ; Hendrickson RC; Deacon DD; Harthun NL; Wagner SN; Hunt DF; Engelhard VH; Slingluff CL
J Immunol; 1996 Dec; 157(11):5027-33. PubMed ID: 8943411
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
Vonderheide RH; Anderson KS; Hahn WC; Butler MO; Schultze JL; Nadler LM
Clin Cancer Res; 2001 Nov; 7(11):3343-8. PubMed ID: 11705846
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
Kawashima I; Tsai V; Southwood S; Takesako K; Sette A; Celis E
Cancer Res; 1999 Jan; 59(2):431-5. PubMed ID: 9927058
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
[TBL] [Abstract][Full Text] [Related]
10. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
[TBL] [Abstract][Full Text] [Related]
11. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
Takahashi T; Irie RF; Nishinaka Y; Hoon DS
Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an HLA-A3 restricted human kidney specific T cell clone.
Poindexter NJ; Steward NS; Mohanakumar T
Hum Immunol; 1999 Oct; 60(10):939-43. PubMed ID: 10566593
[TBL] [Abstract][Full Text] [Related]
13. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development.
Threlkeld SC; Wentworth PA; Kalams SA; Wilkes BM; Ruhl DJ; Keogh E; Sidney J; Southwood S; Walker BD; Sette A
J Immunol; 1997 Aug; 159(4):1648-57. PubMed ID: 9257824
[TBL] [Abstract][Full Text] [Related]
14. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
[TBL] [Abstract][Full Text] [Related]
15. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
[TBL] [Abstract][Full Text] [Related]
16. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
17. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice.
Barra C; Gournier H; Garcia Z; Marche PN; Jouvin-Marche E; Briand P; Fillipi P; Lemonnier FA
J Immunol; 1993 May; 150(9):3681-9. PubMed ID: 7682582
[TBL] [Abstract][Full Text] [Related]
19. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
